• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膦甲酸型无机-有机杂化纳米颗粒用于有效的抗病毒治疗。

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy.

机构信息

Institute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstrasse 15, D-76131 Karlsruhe, Germany.

Helmholtz Center for Infection Research, Inhoffenstraße 7, D-38124 Braunschweig, Germany.

出版信息

ACS Biomater Sci Eng. 2022 Apr 11;8(4):1596-1603. doi: 10.1021/acsbiomaterials.2c00074. Epub 2022 Mar 28.

DOI:10.1021/acsbiomaterials.2c00074
PMID:35344659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9007112/
Abstract

[ZrO][(FCN)(OH)] and Gd[FCN] inorganic-organic hybrid nanoparticles (IOH-NPs) are novel saline antiviral nanocarriers with foscarnet (FCN) as a drug anion. FCN as a pyrophosphate analogue serves as a prototype of a viral DNA polymerase inhibitor. FCN is used for the treatment of herpesvirus infections, including the drug-resistant cytomegalovirus (CMV) and herpes simplex viruses, HSV-1 and HSV-2. The novel [ZrO][(FCN)(OH)] and Gd[FCN] IOH-NPs are characterized by aqueous synthesis, small size (20-30 nm), low material complexity, high biocompatibility, and high drug load (up to 44 wt % FCN per nanoparticle). The antiviral activity of the FCN-type IOH-NPs is probed for the human cytomegalovirus (HCMV). Moreover, the uptake of FCN-type IOH-NPs into vesicles, cytoplasm, and nuclei of nonphagocytic lung epithelial cells is evaluated. As a result, a promising antiviral activity of the FCN-type IOH-NPs that significantly outperforms freely dissolved FCN at the level of clinical formulations is observed, encouraging a future use of FCN-type IOH-NPs for the delivery of antivirals against respiratory viruses.

摘要

[ZrO][(FCN)(OH)]和 Gd[FCN]无机-有机杂化纳米粒子(IOH-NPs)是新型的盐性抗病毒纳米载体,其药物阴离子为膦甲酸(FCN)。作为焦磷酸盐类似物,FCN 可用作病毒 DNA 聚合酶抑制剂的原型。FCN 用于治疗疱疹病毒感染,包括耐药性巨细胞病毒(CMV)和单纯疱疹病毒 1 型和 2 型。新型[ZrO][(FCN)(OH)]和 Gd[FCN] IOH-NPs 的特点是水相合成、粒径小(20-30nm)、材料复杂度低、生物相容性高、药物载量高(每个纳米颗粒高达 44wt%FCN)。研究了 FCN 型 IOH-NPs 对人巨细胞病毒(HCMV)的抗病毒活性。此外,还评估了 FCN 型 IOH-NPs 进入非吞噬性肺上皮细胞的囊泡、细胞质和细胞核的摄取情况。结果表明,与游离 FCN 相比,FCN 型 IOH-NPs 具有显著的抗病毒活性,明显优于临床制剂水平,这为 FCN 型 IOH-NPs 用于呼吸道病毒抗病毒药物的递送提供了未来应用的可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/42e0b6566d49/ab2c00074_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/63ef0e2cf9cf/ab2c00074_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/03e9197b4d25/ab2c00074_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/50f3f562cfe2/ab2c00074_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/29c9cd21c0f2/ab2c00074_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/42e0b6566d49/ab2c00074_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/63ef0e2cf9cf/ab2c00074_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/03e9197b4d25/ab2c00074_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/50f3f562cfe2/ab2c00074_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/29c9cd21c0f2/ab2c00074_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa8/9007112/42e0b6566d49/ab2c00074_0006.jpg

相似文献

1
Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy.膦甲酸型无机-有机杂化纳米颗粒用于有效的抗病毒治疗。
ACS Biomater Sci Eng. 2022 Apr 11;8(4):1596-1603. doi: 10.1021/acsbiomaterials.2c00074. Epub 2022 Mar 28.
2
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.单纯疱疹病毒1型和人巨细胞病毒DNA聚合酶N螺旋中W781V和W780V突变对抗病毒药物敏感性的对比效应
J Virol. 2015 Apr;89(8):4636-44. doi: 10.1128/JVI.03360-14. Epub 2015 Feb 11.
3
Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.HSV-1 和 HCMV DNA 聚合酶区域 II 中密码子 715 处各种取代的差异影响。
Antiviral Res. 2021 Apr;188:105046. doi: 10.1016/j.antiviral.2021.105046. Epub 2021 Feb 12.
4
Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.单纯疱疹病毒 1 和人巨细胞病毒 DNA 聚合酶中 II 区和 K 螺旋的氨基酸取代对膦甲酸钠耐药性的影响。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0039021. doi: 10.1128/AAC.00390-21.
5
Neoglycolipid conjugates of foscarnet with enhanced antiviral activity in cells infected with human cytomegalovirus and herpes simplex virus type 1.膦甲酸钠的新糖脂缀合物在感染人巨细胞病毒和1型单纯疱疹病毒的细胞中具有增强的抗病毒活性。
Antivir Chem Chemother. 1999 Nov;10(6):333-45. doi: 10.1177/095632029901000605.
6
Fluorescent Sulfonate-Based Inorganic-Organic Hybrid Nanoparticles for Staining and Imaging.基于荧光磺酸盐的无机-有机杂化纳米粒子用于染色和成像。
Bioconjug Chem. 2018 Aug 15;29(8):2818-2828. doi: 10.1021/acs.bioconjchem.8b00423. Epub 2018 Jul 30.
7
Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.高度选择性的器官分布和细胞摄取的无机-有机杂化纳米颗粒,专门用于靶向输送糖皮质激素。
J Control Release. 2020 Mar 10;319:360-370. doi: 10.1016/j.jconrel.2020.01.010. Epub 2020 Jan 7.
8
Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.膦甲酸的烷基硫代甘油前药:在人巨细胞病毒、单纯疱疹病毒1型和人类免疫缺陷病毒1型感染细胞中的合成、口服生物利用度及构效关系研究
Antivir Chem Chemother. 1998 Jan;9(1):33-40. doi: 10.1177/095632029800900104.
9
Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.源自对膦甲酸敏感的单纯疱疹病毒1型(HSV-1)的耐膦甲酸单纯疱疹病毒1型(HSV-1)的DNA聚合酶基因分型及对抗病毒化合物的敏感性
Antimicrob Agents Chemother. 2005 Feb;49(2):606-11. doi: 10.1128/AAC.49.2.606-611.2005.
10
Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.膦甲酸钠的烷氧基丙烷前药:烷基链长度对感染HIV-1、HSV-1和HCMV的细胞体外抗病毒活性的影响。
Antiviral Res. 1997 Sep;36(1):43-53. doi: 10.1016/s0166-3542(97)00039-9.

引用本文的文献

1
Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy.变革癌症免疫疗法:新兴的纳米技术驱动药物递送系统以提高治疗效果。
ACS Meas Sci Au. 2024 Nov 15;5(1):31-55. doi: 10.1021/acsmeasuresciau.4c00062. eCollection 2025 Feb 19.
2
Navigating Latency-Inducing Viral Infections: Therapeutic Targeting and Nanoparticle Utilization.应对潜伏期诱导性病毒感染:治疗靶点与纳米颗粒的应用
Biomater Res. 2024 Oct 16;28:0078. doi: 10.34133/bmr.0078. eCollection 2024.
3
Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19.

本文引用的文献

1
Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies.脂质聚合物杂化纳米载体作为一种由计算研究支持的不同抗SARS-CoV-2药物的组合平台。
RSC Adv. 2021 Aug 27;11(46):28876-28891. doi: 10.1039/d1ra04576h. eCollection 2021 Aug 23.
2
Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.受生物启发的药物传递策略可用于重新利用常规抗生素来对抗细胞内感染。
Adv Drug Deliv Rev. 2021 Oct;177:113948. doi: 10.1016/j.addr.2021.113948. Epub 2021 Aug 28.
3
A Novel Triple-Fluorescent HCMV Strain Reveals Gene Expression Dynamics and Anti-Herpesviral Drug Mechanisms.
针对细小病毒 B19 的抗病毒药物和纳米技术增强型方法。
Front Cell Infect Microbiol. 2022 Jun 20;12:916012. doi: 10.3389/fcimb.2022.916012. eCollection 2022.
一种新型三重荧光 HCMV 株揭示了基因表达动力学和抗疱疹病毒药物机制。
Front Cell Infect Microbiol. 2021 Jan 8;10:536150. doi: 10.3389/fcimb.2020.536150. eCollection 2020.
4
Nanotechnology for COVID-19: Therapeutics and Vaccine Research.纳米技术在新冠病毒防治中的应用:治疗方法和疫苗研究。
ACS Nano. 2020 Jul 28;14(7):7760-7782. doi: 10.1021/acsnano.0c04006. Epub 2020 Jun 29.
5
Spiky Nanostructures with Geometry-matching Topography for Virus Inhibition.具有几何匹配形貌的刺状纳米结构用于病毒抑制。
Nano Lett. 2020 Jul 8;20(7):5367-5375. doi: 10.1021/acs.nanolett.0c01723. Epub 2020 Jun 9.
6
Imaging-assisted anticancer nanotherapy.影像辅助抗癌纳米治疗。
Theranostics. 2020 Jan 1;10(3):956-967. doi: 10.7150/thno.38288. eCollection 2020.
7
Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.高度选择性的器官分布和细胞摄取的无机-有机杂化纳米颗粒,专门用于靶向输送糖皮质激素。
J Control Release. 2020 Mar 10;319:360-370. doi: 10.1016/j.jconrel.2020.01.010. Epub 2020 Jan 7.
8
Nanoparticles in the clinic: An update.临床中的纳米颗粒:最新进展
Bioeng Transl Med. 2019 Sep 5;4(3):e10143. doi: 10.1002/btm2.10143. eCollection 2019 Sep.
9
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.基于通路的突变数据分析对癌症靶向药物评分很有效。
Front Pharmacol. 2019 Jan 23;10:1. doi: 10.3389/fphar.2019.00001. eCollection 2019.
10
Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.治疗性荧光杂化纳米颗粒,用于将糖皮质激素追踪递送至炎症部位。
Theranostics. 2018 Dec 7;8(22):6367-6383. doi: 10.7150/thno.28324. eCollection 2018.